Report post

What are argenica Therapeutics shares worth?

Argenica Therapeutics is a biotechnology business based in Australia. Argenica Therapeutics shares (AGN) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Argenica Therapeutics has a trailing 12-month revenue of around $296,075. If you're looking to buy shares, check out the steps below.

What is argenica Therapeutics Ltd (ASX AGN)?

Its lead product candidate is ARG-007, a neuroprotective peptide candidate use to protect brain cells and reduce cell death during a stroke and other types of neural injuries. Argenica Therapeutics Limited was incorporated in 2019 and is based in Nedlands, Australia. View the real-time Argenica Therapeutics Ltd (ASX AGN) share price.

When did argenica Therapeutics Ltd (ASX) close?

On Monday, Argenica Therapeutics Ltd (AGN:ASX) closed at 0.75, -6.25% below its 52-week high of 0.80, set on May 30, 2024. Data delayed at least 20 minutes, as of Jun 03 2024 07:10 BST. All markets data located on FT.com is subject to the FT Terms & Conditions

The World's Leading Crypto Trading Platform

Get my welcome gifts